Curtana Pharmaceuticals Company
Curtana is a biopharmaceutical company that has developed therapies for the treatment of the most aggressive types of brain cancer.
Estimated Revenue:
Less than $1M
Funding Status:
Seed
Industry:
Biopharma, Biotechnology, Pharmaceutical
Investors Number:
3
Last Funding Date:
2017
Technology:
Small Molecules
Founded Date:
2013
Investor Type:
Seed
Headquarters:
Austin, Texas, United States
Total Funding:
52288
Last Funding Type:
Grant
Employee Number:
1-10